Balance Sheet
Cash Flow Statement
Amortization of GoodwillCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amn Healthcare Services (AMN) Asset Writedowns and Impairment (2016 - 2021)

Historic Asset Writedowns and Impairment for Amn Healthcare Services (AMN) over the last 13 years, with Q1 2021 value amounting to $158000.0.

  • Amn Healthcare Services' Asset Writedowns and Impairment changed N/A to $158000.0 in Q1 2021 from the same period last year, while for Dec 2021 it was $158000.0, marking a year-over-year decrease of 9681.19%. This contributed to the annual value of $158000.0 for FY2021, which is 9681.19% down from last year.
  • Amn Healthcare Services' Asset Writedowns and Impairment amounted to $158000.0 in Q1 2021.
  • In the past 5 years, Amn Healthcare Services' Asset Writedowns and Impairment registered a high of $6.3 million during Q4 2019, and its lowest value of -$5.0 million during Q3 2019.
  • Over the past 5 years, Amn Healthcare Services' median Asset Writedowns and Impairment value was $2.3 million (recorded in 2017), while the average stood at $2.0 million.
  • Per our database at Business Quant, Amn Healthcare Services' Asset Writedowns and Impairment plummeted by 44786.86% in 2019 and then soared by 13561.67% in 2020.
  • Quarter analysis of 5 years shows Amn Healthcare Services' Asset Writedowns and Impairment stood at $1.3 million in 2017, then surged by 108.44% to $2.8 million in 2018, then surged by 126.86% to $6.3 million in 2019, then crashed by 49.27% to $3.2 million in 2020, then plummeted by 95.04% to $158000.0 in 2021.
  • Its Asset Writedowns and Impairment stands at $158000.0 for Q1 2021, versus $3.2 million for Q4 2020 and $1.8 million for Q3 2020.